No Licence Renewal For Blood Centres Sans Hospital

Dehradun: All blood centres operating outside of hospitals in Uttarakhand will no longer be eligible for licence renewal, a circular issued on Saturday by the Uttarakhand Food and Drug Authority (FDA) said.

Currently, 82 blood centres are operational in the state, and this directive is expected to impact 30-35 of them, a source in the department said. However, centres run by organisations like Indian Medical Association (IMA) or those under Red Cross will not be affected, as they are classified as charity organisations, according to officials.

Existing centres with a five-year licence will not have to establish a hospital, but once the licences expire, they will not be renewed unless they have moved into hospital premises.

Tajber Singh, additional commissioner, state Food and Drug Administration, said, “Affiliation with any hospital won’t help. Blood centres must be within hospital premises, to ensure that patients in need of blood and plasma receive priority. It also promotes strict preservation of blood as per protocols.”

The move is expected to curb high prices charged by private blood banks during crises and to address issues of incorrect blood transfusions by promoting proper testing and storage of blood.

Related Posts

Puresta launches EVERQ, AI-powered skin-health platform

Puresta Lifestyle Private Limited announced the launch of EVERQ, an AI-powered skin-health platform designed to bring skin assessment, dermatologist consultations, personalised treatment and ongoing skincare together in one connected journey.…

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell interventions that have not been approved for routine clinical use, including those offered for autism, should not be provided as routine, standard or commercial clinical services, the advisory…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre

US FDA launches expedited IND Pilot, begins accepting applications

US FDA launches expedited IND Pilot, begins accepting applications

PIL in SC seeks time-bound probe, stringent action against fake drug networks

PIL in SC seeks time-bound probe, stringent action against fake drug networks

Ghaziabad: Fake supplement racket busted, 5 held

Ghaziabad: Fake supplement racket busted, 5 held

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records